| Literature DB >> 16646042 |
Tristan Mirault1, David Launay, Laurence Cuisset, Eric Hachulla, Marc Lambert, Viviane Queyrel, Thomas Quemeneur, Sandrine Morell-Dubois, Pierre-Yves Hatron.
Abstract
Muckle-Wells syndrome (MWS) is a dominantly inherited autoinflammatory disease characterized by rashes, fever, arthralgia, sensorineural deafness, and the possible development of systemic AA amyloidosis. We used anakinra to treat a 22-year-old patient with MWS who had deafness and a high serum level of C-reactive protein (CRP). Following treatment with anakinra, the patient's CRP level normalized, and she recovered from deafness. The fact that this occurrence has never been previously reported strengthens the role of anakinra in MWS but also raises new questions about the physiopathology of such deafness.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16646042 DOI: 10.1002/art.21807
Source DB: PubMed Journal: Arthritis Rheum ISSN: 0004-3591